Portfolio company
Gene Therapy Delivery Methods
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Sonothera Therapeutics
This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
Chameleon Biosciences
This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
Code Bio
This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.
